On April 26, 2023, Dr. Borade, an Audit Committee member, notified the Company of his intent to resign as a member of the Board effective April 26, 2023.
Key facts
Extracted from this filing and checked against the source text.
Iris Acquisition Corp received a nasdaq deficiency notice notice regarding other.
Exchange
nasdaq
Notice
deficiency notice
Exact text from the filing
May 2, 2023, Iris Acquition Corp (the “Company”) notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that as a result of the resignation of Shahibhushan Borade (“Dr. Borade”) from the Company’s board of directors (the “Board”) (as described below in
Dr. Shahibhushan Borade resigned as Director at Iris Acquisition Corp.
Action
resigned
Role
Director
Exact text from the filing
On April 26, 2023, Dr. Borade, an Audit Committee member, notified the Company of his intent to resign as a member of the Board effective April 26, 2023.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.